This study is exploring a new way to examine the upper digestive tract (esophagus, stomach, and first part of the small intestine) in people who have had or are considering weight-loss surgery (bariatric patients). It's testing a new, very slim, single-use endoscope (a thin, flexible tube with a camera) called the EvoEndo Endoscopy system. This system goes through the nose (Transnasal Endoscopy) and doesn't require sedation, unlike the usual procedure (Esophagogastroduodenoscopy or EGD) which goes through the mouth and requires sedation. The study wants to see if this new method can safely and effectively evaluate and follow up on stomach and digestive issues in bariatric patients. You might be able to join if you are between 18 and 90 years old, need an upper endoscopy, and are cared for in a metabolic and bariatric clinic. The study is currently unclear on its recruitment status.

Study design

This is an interventional study planning to enroll 100 participants. It compares unsedated Transnasal Endoscopy with sedated Esophagogastroduodenoscopy.

What's involved

Participants will undergo either a Transnasal Endoscopy or an Esophagogastroduodenoscopy. Their experience will be surveyed up to 7 days after the procedure.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed up to 7 days after the procedure to assess their experience.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.